Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of bempedoic acid tablets in patients with primary hyperlipidemia inadequately controlled on statins
CTR20244318Phase 3Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in familial hyperlipidemia, heterozygous familial hypercholesterolemia (HeFH), sponsored by Gan & Lee Pharmaceuticals. Started Nov 2024; status: completed.
02
Drugs
bempedoic acid
03
Conditions
familial hyperlipidemiaheterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on CTR20244318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244318.